Effects of Eugenol on Alzheimer’s Disease-like Manifestations in Insulin- and Aβ-Induced Rat Models
- 9 Downloads
Eugenol is a phenylpropene having antidepressant properties. We investigated the effect of eugenol on amyloid plaques as a hallmark of Alzheimer’s disease (AD) in two AD rat models. In the latter, betaamyloid (Aβ) and insulin amyloid fibrils were injected into the rat hippocampus. After a one week lapse, the rats were treated with 0.01 and 0.02 mg/kg eugenol for two weeks. Passive avoidance learning and memory performance was assessed by measuring the step-through latency (STL). Amyloid plaques in the hippocampus were quantitatively evaluated and statistically analyzed using image processing software and ANOVA. Aβ amyloid was a more potent inducer of the signs related to Alzheimer’s disease than insulin. Eugenol at a 0.01 mg/kg dose improved memory and reduced the number of amyloid plaques significantly (P < 0.001). Possible mechanisms are proposed for the inhibitory effects of eugenol on hippocampus plaques.
KeywordsAlzheimer’s disease eugenol amyloid plaques rat hippocampus step-through latency (STL) thioflavin S
Unable to display preview. Download preview PDF.
- 1.D. J. Selkoe and P. Lansbury, Alzheimer’s Disease Is the Most Common Neurodegenerative Disorder, Lippincott-Raven, Philadelphia (1999).Google Scholar
- 3.M. Medina, Z. S. Khachaturian, M. Rossor, et al., “Toward common mechanisms for risk factors in Alzheimer’s syndrome,” Alzheimers Dement. (N.Y.), 3 , No. 4, 571–578 (2017).Google Scholar
- 7.J. Barnes, L. A. Anderson, and J. D. Phillipson, Herbal Medicines, Pharmaceutical Press, London (2007).Google Scholar
- 12.G. Paxinos and C. Watson, The Rat Brain Atlas in Stereotaxic Coordinates, Acad. Press, San Diego (1998).Google Scholar
- 16.E. Solito and M. Sastre, “Microglia function in Alzheimer’s disease,” Front. Pharmacol., 3, No. 14 (2012), doi: https://doi.org/10.3389/fphar.2012.00014.